The Outcome Measures in Rheumatology (OMERACT) Equity Special Interest Group (SIG) was established in 2008 to create a preliminary core set of outcome measures for clinical trials that can assess equity gaps in healthcare and the effectiveness of interventions to close or narrow gaps between advantaged and disadvantaged populations with musculoskeletal (MSK) conditions. At the OMERACT 11 meeting in 2012, the Equity SIG workshop focused on health assessment scales and their applicability for disadvantaged patients with MSK conditions. The intent was to determine whether the items and domains in 2 common questionnaires, the Health Assessment Questionnaire and the Medical Outcome Study Short Form-36 Survey, are appropriate for the activities a...
Objective. The Outcome Measures in Rheumatology (OMERACT) international consensus initiative has suc...
International audienceObjective. The goal of the Outcome Measures in Rheumatology (OMERACT) 12 (2014...
Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to info...
The Outcome Measures in Rheumatology (OMERACT) Equity Special Interest Group (SIG) was established i...
Copyright © 2017. All rights reserved. Objective: Despite advances integrating patient-centered outc...
Objective. Despite advances integrating patient-centered outcomes into rheumatologic studies, concer...
The workshop Choosing or Developing Instruments held at the Outcome Measures in Rheumatology (OMERAC...
© Copyright 2015 The Journal of Rheumatology. All rights reserved. Objective. The goal of the Outcom...
The workshop Choosing or Developing Instruments held at the Outcome Measures in Rheumatology (OMERAC...
Objective. The goal of the Outcome Measures in Rheumatology (OMERACT) 12 (2014) equity working group...
Objective. The Outcome Measures in Rheumatology (OMERACT) international consensus initiative has suc...
International audienceObjective. The goal of the Outcome Measures in Rheumatology (OMERACT) 12 (2014...
Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to info...
The Outcome Measures in Rheumatology (OMERACT) Equity Special Interest Group (SIG) was established i...
Copyright © 2017. All rights reserved. Objective: Despite advances integrating patient-centered outc...
Objective. Despite advances integrating patient-centered outcomes into rheumatologic studies, concer...
The workshop Choosing or Developing Instruments held at the Outcome Measures in Rheumatology (OMERAC...
© Copyright 2015 The Journal of Rheumatology. All rights reserved. Objective. The goal of the Outcom...
The workshop Choosing or Developing Instruments held at the Outcome Measures in Rheumatology (OMERAC...
Objective. The goal of the Outcome Measures in Rheumatology (OMERACT) 12 (2014) equity working group...
Objective. The Outcome Measures in Rheumatology (OMERACT) international consensus initiative has suc...
International audienceObjective. The goal of the Outcome Measures in Rheumatology (OMERACT) 12 (2014...
Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to info...